Suppr超能文献

瘤内和 Tenon 下皮质类固醇注射治疗难治性眶周和眼眶毛细血管血管瘤。

Intralesional and sub-Tenon's infusion of corticosteroids for treatment of refractory periorbital and orbital capillary haemangioma.

机构信息

Paediatric Ophthalmology Unit, Schneider Children's Medical Centre of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petah Tiqwa, Israel.

出版信息

Eye (Lond). 2009 Jun;23(6):1302-7. doi: 10.1038/eye.2008.300. Epub 2008 Nov 7.

Abstract

PURPOSE

To evaluate the effect of combined intralesional and sub-Tenon's administration of corticosteroids for the treatment of refractory periocular and orbital capillary haemangioma in a retrospective, non-comparative study.

METHODS

Seven infants with resistant periorbital and orbital capillary haemangioma who attended our tertiary centre from 2000 to 2005 were treated with an intralesional injection of a mixture of betamethasone 6 mg/cc and triamcinolone 10 mg/cc, by body weight, together with sub-Tenon's infusion of betamethasone 6 mg/cc and triamcinolone 40 mg/cc of a volume of 1 cc, close to the orbital lesion, in the same session. Visual axis, proptosis, pre- and post-treatment changes in four refractive parameters, and parental satisfaction were evaluated.

RESULTS

None of the babies had proptosis or visual axis obstruction after treatment. Mean spherical power decreased by 22.7% (P=0.06). Mean spherical equivalent decreased in 34%, but the difference was not statistically significant (P=0.09). No early or late ocular side effects were observed. Mean intraocular pressure results were normal before and immediately after treatment, and during the follow-up period. Parental satisfaction score during follow-up was 9/10. Mean time to improvement was 96.43+/-58.3 days.

CONCLUSIONS

Combined local corticosteroid administration by posterior sub-Tenon's infusion and intralesional injection in babies with extensive capillary haemangioma is associated with a satisfactory anatomical and functional outcome and there were no ophthalmic side effects.

摘要

目的

在一项回顾性、非对照研究中,评估皮质类固醇联合局部和经Tenon 囊下给药治疗难治性眶周和眼眶毛细血管血管瘤的效果。

方法

2000 年至 2005 年,我们的三级中心收治了 7 例抵抗性眶周和眼眶毛细血管血管瘤的婴儿,采用每 cc 含 6mg 倍他米松和 10mg 曲安奈德的混合药物进行局部注射,根据体重给药,同时在同一部位进行经 Tenon 囊下注射每 cc 含 6mg 倍他米松和 40mg 曲安奈德的药物,剂量接近眼眶病变。评估视轴、眼球突出度、治疗前后 4 项屈光参数的变化以及家长满意度。

结果

治疗后,没有婴儿出现眼球突出或视轴阻塞。平均球镜屈光度降低 22.7%(P=0.06)。平均等效球镜屈光度降低 34%,但差异无统计学意义(P=0.09)。未观察到早期或晚期眼部副作用。治疗前后及随访期间平均眼压结果正常。随访期间家长满意度评分为 9/10。改善的平均时间为 96.43+/-58.3 天。

结论

对于广泛毛细血管血管瘤的婴儿,采用经 Tenon 囊下输注和局部注射联合皮质类固醇给药,可获得令人满意的解剖和功能结果,且无眼部副作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验